HERBALIFELINE DIN 02248423
Status: Cancelled Post Market
Holder: HERBALIFE INTERNATIONAL OF LUXEMBOURG S À R L
Molecule: EICOSAPENTAENOIC ACID
Health Canada record
| Active ingredient(s) | EICOSAPENTAENOIC ACID 119 MG; DOCOSAHEXAENOIC ACID 78 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | C10AX06 OMEGA-3-TRIGLYCERIDES INCL. OTHER ESTERS AND ACIDS |
| Original market date | 19-Jul-2004 |
| Current status date | 21-Jul-2009 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing EICOSAPENTAENOIC ACID
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02336014 | ALLERDERM EFA-Z PLUS | VIRBAC AH, INC. | Solution | EICOSAPENTAENOIC ACID 58 MG; DOCOSAHEXAENOIC ACID 40 MG; GAMMA-LINOLENIC ACID 16 MG; LINOLENIC ACID 4080 MG; VITAMIN A (RETINOL PALMITATE) 1088 UNIT; VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 15 UNIT; VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 800 MCG; BIOTIN 16 MCG; INOSITOL 3 MG; ZINC (ZINC SULFATE) 16.8 MG | Cancelled Post Market |
International API supply for EICOSAPENTAENOIC ACID
2 active FDA Drug Master Files.
Request a quote for HERBALIFELINE